These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23754224)

  • 21. Use of methylation sensitive polymerase chain reaction for detection of fragile X full mutation & carrier state in males.
    Karunasagar A; Pandit L; Kumar S; Karunasagar I; Karunasagar I
    Indian J Med Res; 2005 Nov; 122(5):429-33. PubMed ID: 16456258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining the role of the CGGBP1 protein in FMR1 gene expression.
    Goracci M; Lanni S; Mancano G; Palumbo F; Chiurazzi P; Neri G; Tabolacci E
    Eur J Hum Genet; 2016 May; 24(5):697-703. PubMed ID: 26306647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-molecule polymerase chain reaction reduces bias: application to DNA methylation analysis by bisulfite sequencing.
    Chhibber A; Schroeder BG
    Anal Biochem; 2008 Jun; 377(1):46-54. PubMed ID: 18358818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Fragile X premutation: new insights and clinical consequences.
    Van Esch H
    Eur J Med Genet; 2006; 49(1):1-8. PubMed ID: 16473304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide screening for genes involved in the epigenetic basis of fragile X syndrome.
    Vershkov D; Yilmaz A; Yanuka O; Nielsen AL; Benvenisty N
    Stem Cell Reports; 2022 May; 17(5):1048-1058. PubMed ID: 35427485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion in the FMR1 gene in a fragile-X male.
    Mannermaa A; Pulkkinen L; Kajanoja E; Ryynänen M; Saarikoski S
    Am J Med Genet; 1996 Aug; 64(2):293-5. PubMed ID: 8844068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular diagnosis of Fragile X syndrome.
    Sofocleous C; Kolialexi A; Mavrou A
    Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome.
    Tabolacci E; Palumbo F; Nobile V; Neri G
    Genes (Basel); 2016 Aug; 7(8):. PubMed ID: 27548224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
    Karius T; Schnekenburger M; Ghelfi J; Walter J; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Jun; 81(11):1329-42. PubMed ID: 21453686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methylation and expression of the FMR1 gene].
    Pintado E; Morón FJ
    Rev Neurol; 2001 Oct; 33 Suppl 1():S57-62. PubMed ID: 12447821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide epigenetic analysis of human pluripotent stem cells by ChIP and ChIP-Seq.
    Hitchler MJ; Rice JC
    Methods Mol Biol; 2011; 767():253-67. PubMed ID: 21822881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained expression of FMR1 mRNA from reactivated fragile X syndrome alleles after treatment with small molecules that prevent trimethylation of H3K27.
    Kumari D; Usdin K
    Hum Mol Genet; 2016 Sep; 25(17):3689-3698. PubMed ID: 27378697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The active FMR1 promoter is associated with a large domain of altered chromatin conformation with embedded local histone modifications.
    Gheldof N; Tabuchi TM; Dekker J
    Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12463-8. PubMed ID: 16891414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
    Al-Mahdawi S; Pinto RM; Ismail O; Varshney D; Lymperi S; Sandi C; Trabzuni D; Pook M
    Hum Mol Genet; 2008 Mar; 17(5):735-46. PubMed ID: 18045775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic characterization of the FMR1 promoter in induced pluripotent stem cells from human fibroblasts carrying an unmethylated full mutation.
    de Esch CE; Ghazvini M; Loos F; Schelling-Kazaryan N; Widagdo W; Munshi ST; van der Wal E; Douben H; Gunhanlar N; Kushner SA; Pijnappel WW; de Vrij FM; Geijsen N; Gribnau J; Willemsen R
    Stem Cell Reports; 2014 Oct; 3(4):548-55. PubMed ID: 25358783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells.
    Coffee B; Zhang F; Warren ST; Reines D
    Nat Genet; 1999 May; 22(1):98-101. PubMed ID: 10319871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rare variants in the promoter of the fragile X syndrome gene (FMR1).
    Milà M; Castellví-Bel S; Sánchez A; Barceló A; Badenas C; Mallolas J; Estivill X
    Mol Cell Probes; 2000 Apr; 14(2):115-9. PubMed ID: 10799273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular-intelligence correlations in young fragile X males with a mild CGG repeat expansion in the FMR1 gene.
    Steyaert J; Borghgraef M; Legius E; Fryns JP
    Am J Med Genet; 1996 Aug; 64(2):274-7. PubMed ID: 8844064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FMR1 expression in human granulosa cells and variable ovarian response: control by epigenetic mechanisms.
    Rehnitz J; Youness B; Nguyen XP; Dietrich JE; Roesner S; Messmer B; Strowitzki T; Vogt PH
    Mol Hum Reprod; 2021 Feb; 27(2):. PubMed ID: 33493269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental therapy: reactivation of the FMR1 gene involved in fragile X syndrome].
    Chiurazzi P; Neri G
    Rev Neurol; 2001 Oct; 33 Suppl 1():S62-5. PubMed ID: 12447822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.